
### [NCIT:C4583](http://purl.obolibrary.org/obo/NCIT_C4583)
**Label:** Metastatic Malignant Neoplasm in the Peritoneum

**Subclasses:** [NCIT:C3345](http://purl.obolibrary.org/obo/NCIT_C3345) (Pseudomyxoma Peritonei), [NCIT:C27382](http://purl.obolibrary.org/obo/NCIT_C27382) (Peritoneal Carcinomatosis), 

**Class expressions from DL-Learner:**

- [UBERON:0003684](http://purl.obolibrary.org/obo/UBERON_0003684) (abdominal cavity) 60.00%
- [UBERON:0002358](http://purl.obolibrary.org/obo/UBERON_0002358) (peritoneum) 60.00%
- [NCIT:C41444](http://purl.obolibrary.org/obo/NCIT_C41444) (Secondary Lesion) 60.00%
- [NCIT:C40557](http://purl.obolibrary.org/obo/NCIT_C40557) (Metastatic Lesion) 60.00%
- Thing 51.79%
- [NCIT:C3824](http://purl.obolibrary.org/obo/NCIT_C3824) (Lesion) 28.91%
- [UBERON:0000042](http://purl.obolibrary.org/obo/UBERON_0000042) (serous membrane) 28.90%
- [NCIT:C3367](http://purl.obolibrary.org/obo/NCIT_C3367) (Finding) 22.53%
- [NCIT:C7057](http://purl.obolibrary.org/obo/NCIT_C7057) (Disease, Disorder or Finding) 22.15%
- [UBERON:0001062](http://purl.obolibrary.org/obo/UBERON_0001062) (anatomical entity) 22.14%
- [BFO:0000004](http://purl.obolibrary.org/obo/BFO_0000004) (null) 22.01%
- [BFO:0000002](http://purl.obolibrary.org/obo/BFO_0000002) (null) 22.01%
- [UBERON:0000466](http://purl.obolibrary.org/obo/UBERON_0000466) (immaterial anatomical entity) 19.62%
- [BFO:0000141](http://purl.obolibrary.org/obo/BFO_0000141) (null) 19.62%
- [NCIT:C12917](http://purl.obolibrary.org/obo/NCIT_C12917) (Malignant Cell) 13.24%


